TY  - GEN
AU  - Nahid,Payam
AU  - Dorman,Susan E
AU  - Alipanah,Narges
AU  - Barry,Pennan M
AU  - Brozek,Jan L
AU  - Cattamanchi,Adithya
AU  - Chaisson,Lelia H
AU  - Chaisson,Richard E
AU  - Daley,Charles L
AU  - Grzemska,Malgosia
AU  - Higashi,Julie M
AU  - Ho,Christine S
AU  - Hopewell,Philip C
AU  - Keshavjee,Salmaan A
AU  - Lienhardt,Christian
AU  - Menzies,Richard
AU  - Merrifield,Cynthia
AU  - Narita,Masahiro
AU  - O'Brien,Rick
AU  - Peloquin,Charles A
AU  - Raftery,Ann
AU  - Saukkonen,Jussi
AU  - Schaaf,H Simon
AU  - Sotgiu,Giovanni
AU  - Starke,Jeffrey R
AU  - Migliori,Giovanni Battista
AU  - Vernon,Andrew
TI  - Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
SN  - 1537-6591
PY  - 2017///1227
KW  - Antitubercular Agents
KW  - therapeutic use
KW  - HIV Infections
KW  - complications
KW  - Humans
KW  - Mycobacterium tuberculosis
KW  - Public Health
KW  - Tuberculosis
KW  - diagnosis
N1  - Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/cid/ciw566
ER  -